← Back to NSE Circulars
NSE Circular · NSE/CML/77090

Listing of Equity Shares of Sudarshan Pharma Industries Limited pursuant to Migration from SME Platform of BSE to Capital Market Segment (Main Board) of National Stock Exchange of India Limited

23 Oct 2026

English

NSE Circular: Listing of Equity Shares of Sudarshan Pharma Industries Limited pursuant to Migration from SME Platform of BSE to Capital Market Segment (Main Board) of National Stock Exchange of India Limited

NSE has issued a circular dated 23 Oct 2026, under reference NSE/CML/77090. The circular subject is: Listing of Equity Shares of Sudarshan Pharma Industries Limited pursuant to Migration from SME Platform of BSE to Capital Market Segment (Main Board) of National Stock Exchange of India Limited.
Official NSE Circular

Reference: NSE/CML/77090
Date: 23 Oct 2026
Category: Listing
Department: Listing

Summary
NSE has issued a circular dated 23 Oct 2026, under reference NSE/CML/77090. The circular subject is: Listing of Equity Shares of Sudarshan Pharma Industries Limited pursuant to Migration from SME Platform of BSE to Capital Market Segment (Main Board) of National Stock Exchange of India Limited.

Source
https://nsearchives.nseindia.com/content/circulars/CML77090.zip

Readers should refer to the official NSE circular for complete details.

தமிழ்

NSE சுற்றறிக்கை: Listing of Equity Shares of Sudarshan Pharma Industries Limited pursuant to Migration from SME Platform of BSE to Capital Market Segment (Main Board) of National Stock Exchange of India Limited

NSE, 23 Oct 2026 அன்று NSE/CML/77090 என்ற குறிப்புடன் ஒரு சுற்றறிக்கையை வெளியிட்டுள்ளது. சுற்றறிக்கையின் பொருள்: Listing of Equity Shares of Sudarshan Pharma Industries Limited pursuant to Migration from SME Platform of BSE to Capital Market Segment (Main Board) of National Stock Exchange of India Limited.
அதிகாரப்பூர்வ NSE சுற்றறிக்கை

குறிப்பு: NSE/CML/77090
தேதி: 23 Oct 2026
வகை: Listing
துறை: Listing

சுருக்கம்
NSE, 23 Oct 2026 அன்று NSE/CML/77090 என்ற குறிப்புடன் ஒரு சுற்றறிக்கையை வெளியிட்டுள்ளது. சுற்றறிக்கையின் பொருள்: Listing of Equity Shares of Sudarshan Pharma Industries Limited pursuant to Migration from SME Platform of BSE to Capital Market Segment (Main Board) of National Stock Exchange of India Limited.

மூலம்
https://nsearchives.nseindia.com/content/circulars/CML77090.zip

முழுமையான விவரங்களுக்கு அதிகாரப்பூர்வ NSE சுற்றறிக்கையைப் பார்க்கவும்.
View official NSE circular (PDF) ↗